ANG Lifesciences India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from ANG Lifesciences India Ltd. on BSE

Search Inside the pdf :

ANG Lifesciences India Ltd.

14 Aug 2025

26.71

-4.68%

Result

ANG Lifesciences India Ltd - 540694 - Standalone & Consolidated Unaudited Financial Results For The Quarter …

BSE India

We hereby submitting the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30.06.2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	24.71	18.42	17.54	34.1%	40.9%
Operating Profit Qtr	1.85	-0.36	-1.93	613.9%	195.9%
Net Profit Qtr	-0.79	-1.94	-2.77	59.3%	71.5%
Earning Per Share Adjusted latest Qtr	-0.60	-1.48	-2.12	59.5%	71.7%

* Standalone data

Detailed Results

ANG Lifesciences India Ltd.

14 Aug 2025

26.71

-4.68%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Submission …

BSE India

We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended as on 30.06.2025 along with the Auditors limited review reports thereon.

pdf

ANG Lifesciences India Ltd.

06 Aug 2025

26.71

-4.68%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Conducting Board Meeting To Consider …

BSE India

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter ended 30th June, 2025. 2. Any other business that may be necessary with the permission of Chairman.

pdf

ANG Lifesciences India Ltd.

16 Jul 2025

26.71

-4.68%

Company Update

ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025.

pdf

ANG Lifesciences India Ltd.

21 Jun 2025

26.71

-4.68%

SAST

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

BSE India

Closure of Trading Window.

pdf

ANG Lifesciences India Ltd.

12 Jun 2025

26.71

-4.68%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper disclosure for the FY ended 31.03.2025.

pdf

ANG Lifesciences India Ltd.

30 May 2025

26.71

-4.68%

Result

ANG Lifesciences India Ltd - 540694 - Financial Year Results For The Year Ended 31.03.2025

BSE India

Financial year Results for the year ended 31.03.2025

pdf

ANG Lifesciences India Ltd.

30 May 2025

26.71

-4.68%

Result

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that at the Board Meeting held today i.e. on Friday, 30th May, 2025, and have Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March, 2025. The said Audited Financial Results were reviewed by Audit Committee and thereafter approved by the Board of Directors.

pdf

ANG Lifesciences India Ltd.

22 May 2025

26.71

-4.68%

Company Update

ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24(A) of SEBI(LODR), Regulations, 2015, enclosed is the Annual Secretarial Compliance Report for the year ended on 31.03.2025

pdf

ANG Lifesciences India Ltd.

22 May 2025

26.71

-4.68%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant …

BSE India

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 30th May, 2025 at 05:30 P.M. at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001, inter alia transact the following business: 1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2025. 2. Any other business that may be necessary with the permission of Chairman.

pdf

Is ANG Lifesciences India Ltd. worth buying?

61 Votes:

Buy 77.05%

Sell 11.48%

Hold 11.48%